Samalin Investment Counsel LLC raised its stake in Abrdn Healthcare Investors (NYSE:HQH – Free Report) by 7.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 72,844 shares of the financial services provider’s stock after buying an additional 4,875 shares during the period. Samalin Investment Counsel LLC’s holdings in Abrdn Healthcare Investors were worth $1,169,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in HQH. Raymond James Financial Inc. purchased a new stake in Abrdn Healthcare Investors in the 4th quarter valued at $15,049,000. Penserra Capital Management LLC purchased a new stake in Abrdn Healthcare Investors in the 3rd quarter valued at $16,145,000. Wolverine Asset Management LLC purchased a new stake in Abrdn Healthcare Investors in the 4th quarter valued at $2,196,000. Absolute Investment Advisers LLC purchased a new stake in Abrdn Healthcare Investors in the 4th quarter valued at $1,786,000. Finally, Oppenheimer & Co. Inc. grew its holdings in Abrdn Healthcare Investors by 94.6% in the 4th quarter. Oppenheimer & Co. Inc. now owns 174,268 shares of the financial services provider’s stock valued at $2,797,000 after buying an additional 84,731 shares in the last quarter. 32.60% of the stock is currently owned by hedge funds and other institutional investors.
Abrdn Healthcare Investors Stock Performance
Shares of NYSE:HQH opened at $16.70 on Friday. The business has a fifty day moving average of $17.34 and a two-hundred day moving average of $17.65. Abrdn Healthcare Investors has a 52-week low of $15.76 and a 52-week high of $19.79.
Abrdn Healthcare Investors Cuts Dividend
Abrdn Healthcare Investors Company Profile
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Recommended Stories
- Five stocks we like better than Abrdn Healthcare Investors
- Trading Halts Explained
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- What Are Some of the Best Large-Cap Stocks to Buy?
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abrdn Healthcare Investors (NYSE:HQH – Free Report).
Receive News & Ratings for Abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.